Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

ClinicalTrials.gov ID: NCT07213973

Public ClinicalTrials.gov record NCT07213973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Povorcitinib in Adolescents With Moderate to Severe Hidradenitis Suppurativa

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradenitis suppurativa over a 54-week open-label treatment period.

Study identification

NCT ID
NCT07213973
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Incyte Corporation
Industry
Enrollment
40 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 1, 2026
Primary completion
Mar 24, 2028
Completion
Mar 24, 2028
Last update posted
Aug 5, 2026

2026 – 2028

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
24
Facility City State ZIP Site status
University of Alabama At Birmingham Birmingham Alabama 35233 Recruiting
Medical Dermatology Specialists Phoenix Phoenix Arizona 85006 Recruiting
Saguaro Dermatology Phoenix Arizona 85008 Recruiting
Uconn Health Farmington Connecticut 06030 Recruiting
University of Miami Miller School of Medicine Miami Florida 33136 Recruiting
Skin Research of South Florida, Llc Miami Florida 33173 Recruiting
Trueblue Clinical Research Tampa Florida 33607 Recruiting
Advanced Medical Research Pc Sandy Springs Georgia 30328 Recruiting
Endeavor Health Medical Group Skokie Illinois 60077 Recruiting
Dermatology Skin Cancer Center Leawood Leawood Kansas 66211 Recruiting
Equity Medical Bowling Green Kentucky 42104 Recruiting
Johns Hopkins Univ Schl of Medicine Baltimore Maryland 21205 Recruiting
Skin Oasis Dermatology Gambrills Maryland 21054 Not yet recruiting
Boston Childrens Hospital Boston Massachusetts 02115 Recruiting
Oakland Hills Dermatology Pc Auburn Hills Michigan 48326 Recruiting
Wayne State University Physician Group Dermatology Detroit Michigan 48201 Recruiting
Revival Research Institute, Llc Troy Troy Michigan 48084 Recruiting
University of Missouri Kansas City Kansas City Missouri 64108 Not yet recruiting
Washington University St Louis Missouri 63110 Recruiting
Boeson Research Missoula 2825 Fort Missoula Rd Missoula Montana 59804 Recruiting
University of New Mexico Hospital Albuquerque New Mexico 87102 Recruiting
Geisinger Medical Center Danville Pennsylvania 17822 Recruiting
Bellaire Dermatology Associates Bda Bellaire Texas 77401 Recruiting
Texas Dermatology Research Center Dallas Texas 75246 Recruiting
3A Research Llc West Location El Paso Texas 79902 Not yet recruiting
Jordan Valley Dermatology Center South Jordan Utah 84095 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07213973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07213973 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →